Table 2.
Demographic data of the 3 groups at baseline (N=93).
| Characteristics | CBGTa group (n=28) | ICBTb group (n=32) | TAUc group (n=33) | |
| Gender, n (%) | ||||
|
|
Male | 15 (53.6) | 18 (56.3) | 23 (69.7) |
|
|
Female | 13 (46.4) | 14 (43.7) | 10 (30.3) |
| Marital status, n (%) | ||||
|
|
Unmarried | 14 (50.0) | 20 (62.5) | 22 (66.7) |
|
|
Married | 14 (50.0) | 12 (37.5) | 11 (33.0) |
| Age (years) | ||||
|
|
Mean (SD) | 30.29 (8.09) | 29.16 (6.35) | 27.52 (7.73) |
|
|
Min-max (years) | 18-48 | 19-45 | 18-45 |
| Years of education, mean (SD) | 13.82 (2.79) | 13.81 (3.31) | 14.55 (2.41) | |
| History of previous treatment, n (%) | ||||
|
|
Psychiatric medications | 28 (100) | 32 (100) | 33 (100) |
|
|
Traditional Chinese medicine | 0 | 0 | 1 (3.0) |
|
|
Psychological treatment | 0 | 0 | 1 (3.0) |
| Duration of SSRId treatment>8 weeks, n (%) | 26 (92.9) | 24 (75.0) | 29 (87.9) | |
| Present onset form, n (%) | ||||
|
|
Acute (within a month) | 1 (3.6) | 2 (6.3) | 6 (18.2) |
|
|
Subacute | 1 (3.6) | 5 (15.6) | 5 (15.2) |
|
|
Chronic (>3 months) | 26 (92.9) | 25 (78.1) | 22 (66.7) |
| Total duration of the disease, mean (SD) | 7.71 (6.71) | 6.06 (6.18) | 8.96 (6.65) | |
| Age at first onset, mean (SD) | 22.54 (6.61) | 23.78 (7.25) | 18.85 (6.53) | |
| Disease progression, n (%) | ||||
|
|
Persistent | 23 (82.1) | 28 (87.5) | 16 (48.5) |
|
|
Intermittent | 5 (17.9) | 4 (12.5) | 17 (51.5) |
| Family history, n (%) | 3 (10.7) | 1 (3.1) | 8 (24) | |
aCBGT: cognitive behavior group therapy.
bICBT: internet-based cognitive behavior therapy.
cTAU: treatment as usual (conventional medical treatment).
dSSRI: selective serotonin reuptake inhibitor.